» Authors » Anandrao R Kulkarni

Anandrao R Kulkarni

Explore the profile of Anandrao R Kulkarni including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 159
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ganguly K, Kulkarni A, Aminabhavi T
Drug Deliv . 2015 Nov; 23(8):2838-2851. PMID: 26530807
Purpose: Microspheres of chitosan (CS) cross-linked with polyethylene glycol (PEG) were prepared by emulsion-cross-linking followed by the solvent evaporation technique. The formulations were characterized and subjected to in vitro and...
2.
Ganguly K, Kulkarni A, Aminabhavi T
Drug Deliv . 2015 Sep; :1-14. PMID: 26394122
Purpose: Microspheres of chitosan (CS) crosslinked with polyethylene glycol (PEG) were prepared by emulsion crosslinking followed by solvent evaporation technique. The formulations were characterized and subjected to in vitro and...
3.
Chaturvedi K, Ganguly K, Kulkarni A, Rudzinski W, Krauss L, Nadagouda M, et al.
Nanomedicine (Lond) . 2015 May; 10(10):1569-83. PMID: 26008194
Aim: To develop insulin loaded deoxycholic acid conjugated PEGylated polyhydroxybutyrate co-polymeric nanoparticles and carry out in vitro and in vivo testing of enteric coated granules comprising these nanoparticles. Materials &...
4.
Chaturvedi K, Tripathi S, Kulkarni A, Aminabhavi T
J Microencapsul . 2012 Oct; 30(4):356-68. PMID: 23078151
Pharmacokinetics, biodistribution and antitumour activity of 5-fluorouracil (5-FU)-loaded polyhydroxybutyrate (PHB) and cellulose acetate phthalate (CAP) blend microspheres were investigated in chemically induced colorectal cancer in albino male Wistar rats and...
5.
Chaturvedi K, Ganguly K, Kulkarni A, Kulkarni V, Nadagouda M, Rudzinski W, et al.
Expert Opin Drug Deliv . 2011 Aug; 8(11):1455-68. PMID: 21867463
Introduction: The discovery of synthetic small interfering RNA (siRNA) has led to a surge of interest in harnessing RNA interference (RNAi) technology for biomedical applications and drug development. Even though...
6.
Kulkarni A, Lin Y, Liang H, Chang W, Hsiao W, Sung H
J Nanosci Nanotechnol . 2006 Oct; 6(9-10):2867-73. PMID: 17048493
In the study, methoxy polyethyleneglycol (MPEG) linked chitosan (PLC) with a different degrees of substitution were prepared using a novel yet simple method in the presence of formaldehyde in a...
7.
Liang H, Chen C, Chen S, Kulkarni A, Chiu Y, Chen M, et al.
Biomaterials . 2005 Nov; 27(9):2051-9. PMID: 16307794
The study was to develop paclitaxel-loaded formulations using a novel type of self-assembled nanoparticles (P/NPs) composed of block copolymers synthesized by poly(gamma-glutamic acid) and poly(lactide). For the potential of targeting...
8.
Roney C, Kulkarni P, Arora V, Antich P, Bonte F, Wu A, et al.
J Control Release . 2005 Oct; 108(2-3):193-214. PMID: 16246446
Alzheimer's disease (AD) is the most common cause of dementia among the elderly, affecting 5% of Americans over age 65, and 20% over age 80. An excess of senile plaques...
9.
Kulkarni A, Hukkeri V, Sung H, Liang H
Macromol Biosci . 2005 Oct; 5(10):925-8. PMID: 16208628
In this study, a simple method was developed to crosslink chitosan using poly(ethylene glycol) (PEG) with different molecular weights. Crosslinking of chitosan was confirmed by various spectral analyses. The differential...
10.
Kulkarni A, Kulkarni V, Keshavayya J, Hukkeri V, Sung H
Macromol Biosci . 2005 Jun; 5(6):490-3. PMID: 15948225
Thiazolidinone derivatives (TDCs) were prepared by converting chitosan into chitosan's Schiff's bases (CSBs), followed by treatment with mercaptoacetic acid. Both CSBs and TDCs were tested for antimicrobial activity against four...